Next Vial Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: compounded GLP-1, LegitScript-certified, with a named pharmacy partner
Next Vial scores highest on state availability and ease of access.
Semaglutide
then $199/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. LegitScript certified with medication dispensed through Manifest Pharmacy (Greer, SC). No membership required — one transparent price covering consultation, medication, and free shipping. Serves 49 states.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Next Vial
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Next Vial at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 49 states
- FDA status
- No FDA warning letter on record
How we scored Next Vial
Each dimension is scored algorithmically from Next Vial’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $199/mo, Next Vial runs about 18% above the $169 median for GLP-1 providers, and the first month drops to $99.
Effectiveness25%
7.9/10Next Vial offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.0/10Next Vial treats patients in all 50 states.
Support10%
5.6/10Next Vial provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Next Vial review
Last checked August 2026- Confirmed current pricing across 1 dose/plan tier
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199/mo across 1 dose/plan tier — checked August 2026
- State pharmacy licensing & LegitScript status
- LegitScript certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Next Vial
We walked Next Vial’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a 100% online health questionnaire / intake form.
- 2A U.S. board-certified physician reviews records and prescriptions.
- 3Medications are delivered free from accredited pharmacies.
- No price is shown before or after the questionnaire on the pages reviewed, despite an 'upfront pricing' claim.
- States 'no insurance, no waitlist, free delivery' and 'no membership required.'
- Offers compounded and microdose semaglutide and tirzepatide.
GLP-1 medications Next Vial offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Next Vial's current pricing and active discounts before you decide.
What we like
- LegitScript certified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees — one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
Watch-outs
- Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
Is Next Vial worth it?
The short version of what Next Vial offers is compounded GLP-1, LegitScript-certified, with a named pharmacy partner. New patients start at $99/month for the first month, but the price steps up to $199/month once that window ends — so treat the headline number as an intro offer, not the standing rate. It treats patients in every state, so where you live isn't a reason to rule it out.
Worth knowing before you sign up: Next Vial offers a microdosing option and is LegitScript-certified.
How much Next Vial actually costs
- Compounded semaglutide starts at $99 the first month, then $199/month after that, at that tier.
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month. Next Vial's standing rate sits at the premium end of that range, well above the cheapest options in the category. The first-month discount is a great way to start cheaply. Still, price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against Next Vial before you commit.
Medications: what Next Vial prescribes
Next Vial prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Next Vial is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Next Vial treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Next Vial is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $99 intro price steps up to $199/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Next Vial scores highest on state availability and ease of access.
Ready to start with Next Vial?
Starting at $99/month. See current pricing and start your free consultation.
Next Vial might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Ro.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Next Vial review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Next Vial's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.